By the same authors

From the same journal

A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease

Research output: Contribution to journalArticle

Full text download(s)

Published copy (DOI)

Author(s)

  • André R. A. Marques
  • Lianne I. Willems
  • Daniela Herrera Moro
  • Bogdan I. Florea
  • Saskia Scheij
  • Roelof Ottenhoff
  • Cindy P.A.A. van Roomen
  • Marri Verhoek
  • Jessica K. Nelson
  • Wouter W. Kallemeijn
  • Anna Biela-Banas
  • Olivier R. Martin
  • M. Begoña Cachón‐González
  • Nee Na Kim
  • Timothy M. Cox
  • Rolf G. Boot
  • Herman S. Overkleeft
  • Johannes M F G Aerts

Department/unit(s)

Publication details

JournalChembiochem
DateAccepted/In press - 20 Dec 2016
DateE-pub ahead of print - 20 Dec 2016
DatePublished (current) - 31 Jan 2017
Issue number4
Volume18
Number of pages11
Pages (from-to)402-412
Early online date20/12/16
Original languageEnglish

Abstract

Galactosylceramidase (GALC) is the lysosomal β-galactosidase responsible for the hydrolysis of galactosylceramide. Inherited deficiency in GALC causes Krabbe disease, a devastating neurological disorder characterized by accumulation of galactosylceramide and its deacylated counterpart, the toxic sphingoid base galactosylsphingosine (psychosine). We report the design and application of a fluorescently tagged activity-based probe (ABP) for the sensitive and specific labeling of active GALC molecules from various species. The probe consists of a β-galactopyranose-configured cyclophellitol-epoxide core, conferring specificity for GALC, equipped with a BODIPY fluorophore at C6 that allows visualization of active enzyme in cells and tissues. Detection of residual GALC in patient fibroblasts holds great promise for laboratory diagnosis of Krabbe disease. We further describe a procedure for in situ imaging of active GALC in murine brain by intra-cerebroventricular infusion of the ABP. In conclusion, this GALC-specific ABP should find broad applications in diagnosis, drug development, and evaluation of therapy for Krabbe disease.

Bibliographical note

This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

    Research areas

  • beta-galactosidase, fluorescent probes, galactosylceramidase, hydrolase, Krabbe disease

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations